Home / Guides / Semaglutide to tirzepatide

New medicine. Same price at every dose.

Switching from semaglutide to tirzepatide: your starting dose, the timing and the cost

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated

No official chart converts semaglutide to tirzepatide: the Zepbound label, read November 1, 2026, starts everyone at 2.5 mg a week for 4 weeks. Your provider decides from there; at NexLife, compounded tirzepatide is $139 a month on the 12-month plan or $169 month to month, at every dose.

$139/mo on 12 months, every dosePrice Match Guarantee†

  • No official conversion chart between the two medicines
  • Zepbound label: start at 2.5 mg a week for 4 weeks
  • NexLife: $139 a month on 12 months, at every dose
NexLifeSame price at every dose
Illustration of a compounded tirzepatide vial

$139/mo on a 12-month plan, all-inclusive, same price at every dose

Or $169/mo month to month

Switching medicines? A licensed provider reviews your semaglutide dose first

Check my eligibility

About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication

See all 4 plans and what a year costs
Compounded tirzepatide, all in, the same price at every dose
PlanPer month12 months at this rate
12-month Lowest monthly price$139$1,668
6-month$149$1,788
3-month$159$1,908
Month to month$169$2,028

Month to month costs $360 more over 12 months than the 12-month plan. Plans renew until you cancel. Longer plans bill the way you choose at checkout.

Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works

4.8 out of 5 on Trustpilot, 407 reviewsLegitScript-certified

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.

  • Licensed U.S. providers
  • LegitScript certified
  • Free expedited shipping
  • HSA, FSA, Affirm, Klarna, Afterpay
  • 24/7 support, real people
  • Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)

At a glance

What to know before switching from semaglutide to tirzepatide

Switching from semaglutide to tirzepatide at a glance: the Zepbound and Wegovy labels, read November 1, 2026, and NexLife’s prices
QuestionAnswer
Is there a conversion chart?No official one: neither label turns one medicine’s dose into the other’s
Tirzepatide’s starting dose?2.5 mg once a week for 4 weeks, then 5 mg, on the Zepbound label
How does the dose go up?In steps of 2.5 mg, at least 4 weeks apart, up to 15 mg
When’s the first tirzepatide dose?When your provider says. Neither label sets a waiting time, and you don’t take both
Side effects?Mostly stomach side effects, mainly while the dose is going up
Compounded tirzepatide at NexLife?$139 a month on the 12-month plan, or $169 month to month, at every dose

From the Zepbound and Wegovy labels, read November 1, 2026. Your provider decides your dose. Compounded tirzepatide isn’t FDA-approved; Zepbound is.

  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • No official conversion chart: the Zepbound label starts everyone at 2.5 mg a week for 4 weeks. Your provider decides your dose.
  • Steps of 2.5 mg follow, at least 4 weeks apart, up to 15 mg. Online conversion charts are estimates.
  • Don’t take both. Semaglutide’s half-life is about a week, so your provider sets the day of your first tirzepatide dose.
  • Stomach side effects are the ones to expect. On the Zepbound label, most came while the dose was going up.
  • Tirzepatide usually costs more. At NexLife, it’s $20 to $30 a month above compounded semaglutide, depending on the plan.
  • At NexLife, compounded tirzepatide costs the same at every dose: $139 a month on the 12-month plan, or $169 month to month.
NexLife

Switching to tirzepatide? $139/mo on 12 months or $169 month to month, the same at every dose.About 3 minutes of health questions, no insurance needed. Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you.

Check my eligibility

The NexLife Price Match Guarantee†

Paying less elsewhere?
Keep your price. Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

The labels

What do the labels say about starting tirzepatide?

The Zepbound label (revised August 2026) has one starting dose for every use: 2.5 mg once a week for 4 weeks, then 5 mg. It has no separate start for people coming from semaglutide. Your provider decides your dose from your history and how you did on semaglutide, then steps it up from there.

  1. Start: 2.5 mg

    Once a week for 4 weeks. The label calls it a dose for starting treatment, not one to stay on.

  2. Then 5 mg

    After those 4 weeks. 5 mg is the first maintenance dose.

  3. Steps of 2.5 mg

    If your provider raises it, after at least 4 weeks on each dose: 7.5, 10, 12.5 and then 15 mg, the maximum.

  4. A dose that fits you

    The maintenance doses are 5, 10 or 15 mg. If one doesn’t agree with you, the label says to consider a lower one.

Lilly says the same to people switching. On its LillyDirect pharmacy page, Lilly answers “which dose should I start on?” for people coming from another medication. The recommended starting dose is 2.5 mg, and if you’re switching, talk to your provider about the right approach for you.

Mounjaro starts there too. Mounjaro, tirzepatide for type 2 diabetes, also starts at 2.5 mg once a week. Both labels say the slow steps lower the risk of stomach side effects.

The two schedules, side by side

  • Wegovy (semaglutide)

    0.25 mg for 4 weeks, then 0.5, 1 and 1.7 mg, 4 weeks each. Maintenance: 1.7 or 2.4 mg, with up to 7.2 mg after 4 weeks at 2.4 mg.

  • Zepbound (tirzepatide)

    2.5 mg for 4 weeks, then 5 mg. After that, 2.5 mg steps, at least 4 weeks apart. Maintenance: 5, 10 or 15 mg.

Each medicine’s own label schedule (Wegovy, revised June 2026; Zepbound, revised August 2026). Side by side doesn’t mean equal: neither label says a dose of one matches a dose of the other.

Conversion charts

Is there a semaglutide-to-tirzepatide conversion chart?

Not an official one. Neither FDA label converts one medicine’s dose into the other’s, and the two work differently: tirzepatide acts on GIP and GLP-1 receptors, semaglutide on GLP-1 (labels read November 1, 2026). So any chart pairing their doses is an estimate. Bring your current dose, in milligrams, to your provider instead.

Online charts are estimates. Some clinics publish tables that pair a semaglutide dose with a tirzepatide dose. They aren’t from the FDA labels, and they can’t tell you how your body will take a new medicine.

Your provider weighs these instead

  • Your current semaglutide dose, in milligrams, and how long you’ve been on it
  • How you’ve done on it: side effects, and whether your weight is still changing
  • When you took your last dose
  • Your health history and other medicines
  • The label’s starting dose of 2.5 mg

Why going slow matters. The FDA says it has received reports of side effects that may be linked to compounded semaglutide or tirzepatide at higher doses than the approved labels allow. That includes doses raised faster than the labels’ schedules. Some people reported seeking medical care.

Why switch

Why do people switch from semaglutide to tirzepatide?

Four reasons come up most: results, a stall, side effects and price. In the SURMOUNT-5 trial (2025), average loss at 72 weeks was 20.2% on tirzepatide and 13.7% on semaglutide; it studied FDA-approved Zepbound and Wegovy, not compounded versions. A switch is a new prescription, so your provider weighs it with you.

  • Results in the head-to-head trial

    In SURMOUNT-5, adults with obesity lost 20.2% of their body weight on average over 72 weeks on tirzepatide, versus 13.7% on semaglutide. The trial compared starting each medicine; it didn’t test switching. More: tirzepatide vs. semaglutide.

  • A stall

    If your weight has stopped changing, your provider may look at your dose, your routine or a different medicine. Switching is one option, not the only one.

  • Side effects

    Both medicines most often cause stomach side effects. A switch doesn’t promise fewer, and tirzepatide starts with its own dose steps.

  • Price

    Compounded tirzepatide usually costs more than compounded semaglutide. The cost section below has the numbers.

SURMOUNT-5 (The New England Journal of Medicine, 2025) studied FDA-approved Zepbound and Wegovy at the highest dose each person could take. Compounded tirzepatide and semaglutide weren’t studied.

Doing well on semaglutide? Then there’s no need to switch. A licensed provider can help you weigh it.

Timing

When do you take your first tirzepatide dose after semaglutide?

When your provider says. Neither label sets a waiting time for switching. Both say not to take the two medicines together, and semaglutide’s half-life is about a week, per the Wegovy label (revised June 2026). Ask your provider for the day and the dose before your next shot.

  1. Not on top of semaglutide

    The Zepbound label says not to use tirzepatide with any GLP-1 medicine. The Wegovy label says the same about semaglutide.

  2. Semaglutide lingers

    Its half-life is about a week, per the Wegovy label. Some is still in your body for weeks after your last shot.

  3. Your provider sets the day

    Neither label gives a waiting time for switching. Your provider tells you when to take your first tirzepatide dose, and at what dose.

  4. Keep your current plan until then

    Keep taking semaglutide as prescribed until your provider confirms your next step. Questions about timing come to us, 24/7, at (949) 818-8000.

Step by step

How do you switch from semaglutide to tirzepatide, step by step?

No official chart converts one medicine’s dose into the other’s, so a switch follows your provider’s plan and the Zepbound label’s dose steps.

  1. Note your semaglutide dose. Write down your dose in milligrams, not units, your last dose date, how long you’ve been on it and any side effects. Compounded vials come in different strengths, so the same number of units can be a different dose.
  2. See a licensed provider. A switch is a new prescription. Your provider reviews your history and decides whether tirzepatide is right for you, and at what dose.
  3. Don’t take both. Keep taking semaglutide as prescribed until your provider confirms your next step. Each label says not to combine its medicine with another GLP-1, and semaglutide’s half-life is about a week.
  4. Start on the day your provider sets. Neither label sets a waiting time for switching. The Zepbound label starts everyone at 2.5 mg once a week for 4 weeks, then 5 mg; your provider decides your dose.
  5. Step up only as your provider directs. The label’s steps are 2.5 mg, at least 4 weeks apart, up to 15 mg. Most stomach side effects came while the dose was going up, so tell your provider how each dose agrees with you.

From your last semaglutide dose to each tirzepatide step, your provider sets the day and the dose.

In their words

What do the Zepbound label and the FDA say about switching to tirzepatide?

The exact words behind this page’s advice: where the label starts you, why going slow matters and why you don’t take both.

The label has no separate start for people coming from semaglutide. Your provider decides your dose from there.

“The recommended starting dosage of ZEPBOUND for all indications is 2.5 mg injected subcutaneously once weekly for 4 weeks.”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026

Online charts that pair doses are estimates. Why going slow matters, in the FDA’s words:

“Additionally, the agency has received adverse event reports that may be related to patients prescribed compounded semaglutide or tirzepatide products in doses beyond what is in the FDA-approved drug label.”

U.S. Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

Semaglutide is a GLP-1 medicine, so a switch means one at a time. The Wegovy label says the same from its side.

“ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, section 1, revised August 2026

Side effects

Will you have more side effects after switching to tirzepatide?

Maybe at first. Stomach side effects are the most common with both medicines, and they mostly come while a dose is going up. In Zepbound’s 72-week trials, nausea affected 25% to 29% of people, versus 8% on placebo; compounded tirzepatide wasn’t studied. If a dose doesn’t agree with you, your provider can hold it longer.

What the Zepbound label shows. In its two 72-week trials, nausea affected 25% to 29% of people on tirzepatide, versus 8% on placebo. Most nausea, vomiting and diarrhea happened while the dose was going up, and decreased over time. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.

In the head-to-head trial, stomach side effects were the most common in both groups. Most were mild to moderate and came mainly while doses were rising.

If a dose doesn’t agree with you, your provider can keep you on it longer or lower it. Small meals, stopping when you feel full and sipping fluids can help. Here’s more on tirzepatide side effects.

On birth control pills? The Zepbound label says tirzepatide can make them less effective. Switch to a non-oral method, or add a barrier method such as condoms. Do it for 4 weeks after you start, and for 4 weeks after each dose increase.

Severe stomach pain that won’t go away? Stop the medicine and call your provider right away: the label says it can be a sign of pancreatitis. For other questions, call or text us 24/7.

Cost

What does switching to tirzepatide cost?

Tirzepatide usually costs more. In our GLP-1 price index, the middle month-to-month price is $237 for compounded tirzepatide and $199 for semaglutide (checked November 1, 2026). What matters next is whether your price climbs as your dose steps up from 2.5 mg to 15 mg.

At NexLife, per month, all in: the medication, a licensed provider, a nutrition plan, a 1:1 coaching call and free expedited shipping. The same at every dose, so your price doesn’t change as your tirzepatide dose steps up from 2.5 mg.
PlanCompounded semaglutideCompounded tirzepatideDifference
12-month plan$119$139+$20 a month
6-month plan$125$149+$24 a month
3-month plan$132$159+$27 a month
Month to month$139$169+$30 a month

Swipe the table sideways to see every column.

At NexLife, per month, all in: the medication, a licensed provider, a nutrition plan, a 1:1 coaching call and free expedited shipping. The same at every dose, so your price doesn’t change as your tirzepatide dose steps up from 2.5 mg.

Brand-name Zepbound climbs with the dose. At LillyDirect it’s $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg, per 28 days (checked November 1, 2026). The $449 needs a refill within 45 days; otherwise it’s $499 at 7.5 mg and $699 at 10 to 15 mg. A first 12 weeks from 2.5 to 7.5 mg costs $1,147. Compounded tirzepatide isn’t FDA-approved; Zepbound is.

The price match is like for like. Our Price Match Guarantee† matches tirzepatide with tirzepatide and semaglutide with semaglutide. A semaglutide price from another provider isn’t matched on tirzepatide. See the terms.

At NexLife

How does switching from semaglutide to tirzepatide work at NexLife?

A licensed provider reviews your semaglutide history before anything is prescribed. Here’s the path.

  1. Tell us where you are

    Your semaglutide dose in milligrams, your last dose date, how long you’ve been on it and any side effects, in the online health questions.

  2. Your provider reviews the switch

    They review your history and decide whether tirzepatide is right for you, and at what dose. It’s a new prescription.

  3. Your tirzepatide ships

    Free and expedited; most orders ship within 1 to 2 business days.

  4. Your price stays put

    $139 a month on the 12-month plan, or $169 month to month, at every dose. Questions come to us 24/7.

Give your dose in milligrams, not units. Compounded vials come in different strengths, so the same number of units can be a different dose. Here’s how milligrams turn into units: our tirzepatide dosage chart.

Vial math

How many units is your semaglutide dose?

It depends on your vial’s strength. Here are the Wegovy label’s dose steps at two example strengths.

Semaglutide dose steps from the Wegovy label, with the volume and units on a U-100 syringe at two example strengths, 2.5 mg/mL and 5 mg/mL
WeeksWeekly doseAt 2.5 mg/mLAt 5 mg/mL
1 to 40.25 mg0.1 mL (10 units)0.05 mL (5 units)
5 to 80.5 mg0.2 mL (20 units)0.1 mL (10 units)
9 to 121 mg0.4 mL (40 units)0.2 mL (20 units)
13 to 161.7 mg0.68 mL (68 units)0.34 mL (34 units)
17 onward2.4 mg0.96 mL (96 units)0.48 mL (48 units)

The math: mL = dose ÷ strength (mg per mL); units = mL × 100. At 2.5 mg/mL, 1 mg is 1 ÷ 2.5 = 0.4 mL, or 40 units. At 5 mg/mL, the same 1 mg is 0.2 mL, or 20 units.

Both strengths are examples only. The same dose is a different number of units at a different strength, so read the strength on your own vial’s label. Your prescription sets your dose and schedule, which may differ from these label steps. Every step: the semaglutide dosage chart.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $139/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $119/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan; $139/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

Switching to tirzepatide: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

What dose of tirzepatide should I start after semaglutide?

The Zepbound label’s starting dose is 2.5 mg once a week for 4 weeks. It doesn’t give a different start for people coming from semaglutide. Your provider decides, based on your current dose, how you’ve done on it and your health history.

How long should I wait after my last semaglutide shot?

Neither label sets a waiting time, so your provider tells you the day. Don’t take the two together: each label says not to combine it with another GLP-1 medicine, and semaglutide’s half-life is about a week. Keep taking semaglutide as prescribed until your provider confirms your next step.

Is 1 mg of semaglutide the same as 5 mg of tirzepatide?

There’s no official way to say so. They’re different medicines: tirzepatide acts on GIP and GLP-1 receptors, semaglutide on GLP-1. Neither label converts one dose into the other, and charts that pair doses like these are estimates. Bring your current dose, in milligrams, to your provider, who decides where you start.

Will I have more side effects after switching?

You may at first. With both medicines, stomach side effects are the most common and mostly come while the dose is rising. In the Zepbound trials, nausea affected 25% to 29% of people, versus 8% on placebo; those trials studied FDA-approved Zepbound, not compounded tirzepatide.

Can I switch from compounded semaglutide to compounded tirzepatide?

Yes, with a new prescription. A licensed provider reviews your history and decides whether it’s right for you. Compounded tirzepatide isn’t FDA-approved, and a provider prescribes it only when it offers a significant difference for you. At NexLife, it’s $139 a month on the 12-month plan, or $169 month to month, at every dose.

Does tirzepatide cost more than semaglutide?

Usually, yes. In our GLP-1 price index, the middle month-to-month price is $237 for compounded tirzepatide and $199 for semaglutide (checked November 1, 2026). At NexLife, tirzepatide is $139 a month on the 12-month plan and semaglutide $119, each the same at every dose.

Can I switch from tirzepatide back to semaglutide?

Yes, with a new prescription and your provider’s review. The Wegovy label starts semaglutide at 0.25 mg once a week, with steps every 4 weeks, and there’s no official conversion that way either. At NexLife, compounded semaglutide is $119 a month on the 12-month plan, or $139 month to month, at every dose.

Will tirzepatide work if semaglutide stopped working?

No trial has tested that: SURMOUNT-5 compared people starting each medicine, not people switching. In that trial, average loss at 72 weeks was 20.2% on tirzepatide and 13.7% on semaglutide; it studied FDA-approved Zepbound and Wegovy, not compounded versions. Your provider can weigh a switch against other options, such as a dose change.

Does tirzepatide affect birth control pills?

It can. The Zepbound label says tirzepatide can make birth control pills less effective. Switch to a non-oral method, or add a barrier method such as condoms. Do it for 4 weeks after you start, and for 4 weeks after each dose increase. Ask your provider which option fits you.

Should I switch to tirzepatide if semaglutide is working?

There’s no need to. If you’re doing well on semaglutide, a licensed provider can help you weigh a switch, which is a new prescription. If your weight has stopped changing, your provider may look at your dose, your routine or a different medicine: switching is one option, not the only one.

Will NexLife match my semaglutide price if I switch to tirzepatide?

No. The Price Match Guarantee† is like for like: it matches tirzepatide with tirzepatide and semaglutide with semaglutide, so a semaglutide price from another provider isn’t matched on tirzepatide. At NexLife, compounded tirzepatide is $139 a month on the 12-month plan, or $169 month to month, at every dose.

How much does Zepbound cost if I switch from semaglutide?

At LillyDirect, Zepbound is $299 at 2.5 mg and $399 at 5 mg per 28 days, and $449 from 7.5 mg with a refill within 45 days; otherwise it’s $499 at 7.5 mg and $699 at 10 to 15 mg (checked November 1, 2026). Compounded tirzepatide isn’t FDA-approved; Zepbound is.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Labels read and prices checked November 1, 2026.

  • How we checked. Dosing facts come from the prescribing information for Zepbound and Mounjaro (tirzepatide) and Wegovy (semaglutide), read on November 1, 2026. Lilly’s own answer for people switching is on its LillyDirect page. The head-to-head results come from SURMOUNT-5, as published in The New England Journal of Medicine. Prices are each company’s own, with the date we checked them. We don’t give a personal dosing plan: your provider sets your dose.
  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.

Paying less elsewhere? We match it.†

You know the labels and the price. Next: a 3-minute check.

Share your current semaglutide dose, and a licensed provider decides if tirzepatide is right for you. $139 a month on the 12-month plan, or $169 month to month, at every dose.

4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Zepbound (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 1, 2026.
  2. Mounjaro (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 1, 2026.
  3. Wegovy (semaglutide) prescribing information, Novo Nordisk (revised June 2026). Read November 1, 2026.
  4. LillyDirect: Zepbound self-pay prices and switching questions. Checked November 1, 2026.
  5. Aronne LJ et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med 2025;393:26-36. Read October 21, 2026.
  6. FDA: concerns with unapproved GLP-1 drugs used for weight loss (updated October 1, 2026). Read November 1, 2026.
  7. NexLife: pricing, every plan. Checked November 1, 2026.
  8. NexLife: Price Match Guarantee† terms. Read November 1, 2026.
  9. NexLife: GLP-1 price index. Checked November 1, 2026.
  10. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. Read November 2, 2026.
  11. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Read November 2, 2026.
  12. U.S. Food and Drug Administration. Human Drug Compounding Laws. Read November 2, 2026.
  13. U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Read November 2, 2026.
  14. U.S. National Library of Medicine, DailyMed. ZEPBOUND (tirzepatide) injection, solution; ZEPBOUND KWIKPEN (tirzepatide) injection, solution. Label revised August 2026. Read November 2, 2026.
  15. U.S. Food and Drug Administration (Drugs@FDA). Zepbound (tirzepatide) prescribing information, revised February 2026. Read November 2, 2026.